Skip to content
Home/Companies/MedTech/Proscia
Proscia

Proscia

MedTech·US·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Proscia?

Proscia is currently owned by Hitachi Ventures through Hitachi Ventures Fund II (2021 vintage), since 2022.

Hand-verified · updated 2026-07-03

Hitachi Ventures
Investor
Hitachi Ventures
Hitachi Ventures Fund II · 2021 · VC

Key facts

HQUnited States
SectorMedTech
StatusActive
Websiteproscia.com

More from Hitachi Ventures Fund II

Other portfolio companies in the same fund.

ArsenalBio
ArsenalBio
Active
BiotechUS· 2022
Ascend Elements
Active
EnergyUS· 2022
BeZero Carbon
BeZero Carbon
Active
ClimateTechUK· 2022
Makersite
Makersite
Active
SaaSGermany· 2022
Scipher Medicine
Scipher Medicine
Active
HealthTechUS· 2022
Weka
Weka
Active
SoftwareUS· 2022

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Proscia

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Proscia?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Proscia.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue